The AGE-breaker ALT-711 restores high blood flow-dependent remodeling in mesenteric resistance arteries in a rat model of type 2 diabetes

Diabetes

Volumn 61, Issue 6, 2012, Pages 1562-1572

  Freidja, Mohamed L ^a   Tarhouni, Kahena ^a   Toutain, Bertrand ^a   Fassot, Céline ^a   Loufrani, Laurent ^a   Henrion, Daniel ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALAGEBRIUM; ENDOTHELIAL NITRIC OXIDE SYNTHASE; METALLOPROTEINASE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTERY LIGATION; ARTERY RESISTANCE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENTERIC ARTERY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ZUCKER DIABETIC FATTY RAT;

ANIMALS; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; GLYCOSYLATION END PRODUCTS, ADVANCED; MALE; MESENTERIC ARTERIES; RATS; RATS, ZUCKER; THIAZOLES; VASCULAR RESISTANCE; VASODILATION;

EID: 84861856434     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-0750     Document Type: Article

References (48)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053 (Pubitemid 38579764)
2. Goldstein BJ. Insulin resistance as the core defect in type 2 diabetes mellitus. Am J Cardiol 2002;90(5A):3G-10G (Pubitemid 35266675)
3. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005;112:3066-3072 (Pubitemid 43113437)
4. Pieper GM, Siebeneich W. Diabetes-induced endothelial dysfunction is prevented by long-term treatment with the modified iron chelator, hydroxyethyl starch conjugated-deferoxamine. J Cardiovasc Pharmacol 1997;30:734-738 (Pubitemid 28098729)
5. Winer N, Sowers JR. Diabetes and arterial stiffening. Adv Cardiol 2007;44:245-251 (Pubitemid 44763914)
6. Belin de Chantemèle EJ, Vessières E, Guihot AL, et al. Type 2 diabetes severely impairs structural and functional adaptation of rat resistance arteries to chronic changes in blood flow. Cardiovasc Res 2009;81:788-796
7. Pourageaud F, De Mey JG. Vasomotor responses in chronically hyperper-fused and hypoperfused rat mesenteric arteries. Am J Physiol 1998;274:H1301-H1307
8. Tulis DA, Unthank JL, Prewitt RL. Flow-induced arterial remodeling in rat mesenteric vasculature. Am J Physiol 1998;274:H874-H882
9. Bouvet C, Belin de Chantemèle E, Guihot AL, et al. Flow-induced remodeling in resistance arteries from obese Zucker rats is associated with endothelial dysfunction. Hypertension 2007;50:248-254 (Pubitemid 46986048)
10. van den Akker J, Schoorl MJ, Bakker EN, Vanbavel E. Small artery remodeling: current concepts and questions. J Vasc Res 2010;47:183-202
11. Tronc F, Wassef M, Esposito B, Henrion D, Glagov S, Tedgui A. Role of NO in flow-induced remodeling of the rabbit common carotid artery. Arterioscler Thromb Vasc Biol 1996;16:1256-1262 (Pubitemid 26339713)
12. Yan C, Huang A, Kaley G, Sun D. Chronic high blood flow potentiates shear stress-induced release of NO in arteries of aged rats. Am J Physiol Heart Circ Physiol 2007;293:H3105-H3110 (Pubitemid 350106536)
13. Wautier JL, Wautier MP, Schmidt AM, et al. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications. Proc Natl Acad Sci USA 1994;91:7742-7746
14. Portik-Dobos V, Anstadt MP, Hutchinson J, Bannan M, Ergul A. Evidence for a matrix metalloproteinase induction/activation system in arterial vasculature and decreased synthesis and activity in diabetes. Diabetes 2002;51:3063-3068
15. Castier Y, Brandes RP, Leseche G, Tedgui A, Lehoux S. p47phox-dependent NADPH oxidase regulates flow-induced vascular remodeling. Circ Res 2005;97:533-540 (Pubitemid 41361743)
16. Ulrich P, Cerami A. Protein glycation, diabetes, and aging. Recent Prog Horm Res 2001;56:1-21
17. Su J, Lucchesi PA, Gonzalez-Villalobos RA, et al. Role of advanced glycation end products with oxidative stress in resistance artery dysfunction in type 2 diabetic mice. Arterioscler Thromb Vasc Biol 2008;28:1432-1438
18. Loufrani L, Levy BI, Henrion D. Defect in microvascular adaptation to chronic changes in blood flow in mice lacking the gene encoding for dystrophin. Circ Res 2002;91:1183-1189 (Pubitemid 36076368)
19. Pourageaud F, De Mey JG. Structural properties of rat mesenteric small arteries after 4-wk exposure to elevated or reduced blood flow. Am J Physiol 1997;273:H1699-H1706
20. Tuttle JL, Nachreiner RD, Bhuller AS, et al. Shear level influences resistance artery remodeling: wall dimensions, cell density, and eNOS expression. Am J Physiol Heart Circ Physiol 2001;281:H1380-H1389
21. Unthank JL, Nixon JC, Burkhart HM, Fath SW, Dalsing MC. Early collateral and microvascular adaptations to intestinal artery occlusion in rat. Am J Physiol 1996;271:H914-H923
22. Dumont O, Pinaud F, Guihot AL, Baufreton C, Loufrani L, Henrion D. Alteration in flow (shear stress)-induced remodelling in rat resistance arteries with aging: improvement by a treatment with hydralazine. Cardiovasc Res 2008;77:600-608 (Pubitemid 351197657)
23. Driss AB, Devaux C, Henrion D, et al. Hemodynamic stresses induce endothelial dysfunction and remodeling of pulmonary artery in experimental compensated heart failure. Circulation 2000;101:2764-2770 (Pubitemid 30390582)
24. Retailleau K, Belin de Chantemèle EJ, Chanoine S, et al. Reactive oxygen species and cyclooxygenase 2-derived thromboxane A2 reduce angiotensin II type 2 receptor vasorelaxation in diabetic rat resistance arteries. Hypertension 2010;55:339-344
25. Belin de Chantemèle EJ, Retailleau K, Pinaud F, et al. Notch3 is a major regulator of vascular tone in cerebral and tail resistance arteries. Arterioscler Thromb Vasc Biol 2008;28:2216-2224
26. Henrion D, Laher I, Laporte R, Bevan JA. Further evidence from an elastic artery that angiotensin II amplifies noradrenaline-induced contraction through activation of protein kinase C. Eur J Pharmacol 1992;224:13-20
27. Dowell FJ, Henrion D, Benessiano J, Poitevin P, Levy B. Chronic infusion of low-dose angiotensin II potentiates the adrenergic response in vivo. J Hypertens 1996;14:177-182 (Pubitemid 26121859)
28. Vessières E, Belin de Chantemèle EJ, Toutain B, et al. Cyclooxygenase-2 inhibition restored endothelium-mediated relaxation in old obese Zucker rat mesenteric arteries. Front Physiol 2010;1:145
29. Tamarat R, Silvestre JS, Huijberts M, et al. Blockade of advanced glycation end-product formation restores ischemia-induced angiogenesis in diabetic mice. Proc Natl Acad Sci USA 2003;100:8555-8560 (Pubitemid 36842582)
30. Brouwers O, Niessen PM, Haenen G, et al. Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress. Diabetologia 2010;53:989-1000
31. Dumont O, Loufrani L, Henrion D. Key role of the NO-pathway and matrix metalloprotease-9 in high blood flow-induced remodeling of rat resistance arteries. Arterioscler Thromb Vasc Biol 2007;27:317-324 (Pubitemid 46143046)
32. Belin de Chantemèle EJ, Vessières E, Dumont O, et al. Reactive oxygen species are necessary for high flow (shear stress)-induced diameter enlargement of rat resistance arteries. Microcirculation 2009;16:391-402
33. Walter A, Etienne-Selloum N, Sarr M, Kane MO, Beretz A, Schini-Kerth VB. Angiotensin II induces the vascular expression of VEGF and MMP-2 in vivo: preventive effect of red wine polyphenols. J Vasc Res 2008;45:386-394
34. Loufrani L, Li Z, Lévy BI, Paulin D, Henrion D. Excessive microvascular adaptation to changes in blood flow in mice lacking gene encoding for desmin. Arterioscler Thromb Vasc Biol 2002;22:1579-1584
35. Eichmann A, Yuan L, Moyon D, Lenoble F, Pardanaud L, Breant C. Vascular development: from precursor cells to branched arterial and venous networks. Int J Dev Biol 2005;49:259-267 (Pubitemid 40917347)
36. Hilgers RH, Schiffers PM, Aartsen WM, Fazzi GE, Smits JF, De Mey JG. Tissue angiotensin-converting enzyme in imposed and physiological flow-related arterial remodeling in mice. Arterioscler Thromb Vasc Biol 2004;24:892-897 (Pubitemid 38620868)
37. Kojda G, Hambrecht R. Molecular mechanisms of vascular adaptations to exercise: physical activity as an effective antioxidant therapy? Cardiovasc Res 2005;67:187-197 (Pubitemid 40943611)
38. Gorny D, Loufrani L, Kubis N, Lévy BI, Henrion D. Chronic hydralazine improves flow (shear stress)-induced endothelium-dependent dilation in mouse mesenteric resistance arteries in vitro. Microvasc Res 2002;64:127-134 (Pubitemid 34713239)
39. Sorop O, Bakker EN, Pistea A, Spaan JA, VanBavel E. Calcium channel blockade prevents pressure-dependent inward remodeling in isolated subendocardial resistance vessels. Am J Physiol Heart Circ Physiol 2006; 291:H1236-H1245 (Pubitemid 44343668)
40. Heil M, Ziegelhoeffer T,Wagner S, et al. Collateral artery growth (arteriogenesis) after experimental arterial occlusion is impaired in mice lacking CC-chemokine receptor-2. Circ Res 2004;94:671-677 (Pubitemid 38387751)
41. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction: implications for the syndrome of insulin resistance. J Clin Invest 1996;97:2601-2610
42. Endemann DH, Pu Q, De Ciuceis C, et al. Persistent remodeling of resistance arteries in type 2 diabetic patients on antihypertensive treatment. Hypertension 2004;43:399-404 (Pubitemid 38174146)
43. Crijns FR, Wolffenbuttel BH, De Mey JG, Struijker Boudier HA. Mechanical properties of mesenteric arteries in diabetic rats: consequences of outward remodeling. Am J Physiol 1999;276:H1672-H1677 (Pubitemid 29246556)
44. Cooper ME, Rumble J, Komers R, Du HC, Jandeleit K, Chou ST. Diabetes-associated mesenteric vascular hypertrophy is attenuated by angiotensin-converting enzyme inhibition. Diabetes 1994;43:1221-1228 (Pubitemid 24361188)
45. Rumble JR, Cooper ME, Soulis T, et al. Vascular hypertrophy in experimental diabetes: role of advanced glycation end products. J Clin Invest 1997;99:1016-1027 (Pubitemid 27123639)
46. Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 2006;114:597-605 (Pubitemid 44199649)
47. Stirban A, Negrean M, Stratmann B, et al. Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes. Diabetes Care 2006;29:2064-2071 (Pubitemid 44871188)
48. Sun D, Huang A, Koller A, Kaley G. Decreased arteriolar sensitivity to shear stress in adult rats is reversed by chronic exercise activity. Micro-circulation 2002;9:91-97 (Pubitemid 135684685)